Rockwell Medical (RMTI) EBITDA Margin (2010 - 2026)
Rockwell Medical's (RMTI) quarterly EBITDA Margin came in at 8.54% in Q1 2026, down 135.0% YoY from 24.39% in Q1 2025, and down 293.52% on a QoQ basis from 2.17% in Q4 2025.
Rockwell Medical (RMTI) EBITDA Margin (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of EBITDA Margin data on file, last reported at 8.54% in Q1 2026.
- Quarterly EBITDA Margin fell 135.0% year-over-year to 8.54% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.11% (down 769.0% YoY) and the FY2025 annual result came in at 6.77%, down 737.0% from the prior year.
- EBITDA Margin eased to 8.54% in Q1 2026, from 2.17% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 6.84% in Q3 2024 to a low of 41.09% in Q1 2022.
- A 5-year average of 9.64% and a median of 7.31% in 2023 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin jumped 4434 bps — and 2025, when it sank 1678 bps.
- Tracing RMTI's EBITDA Margin over 5 years: stood at 10.18% in 2022, then surged by 76 bps to 2.48% in 2023, then gained by 15 bps to 2.1% in 2024, then decreased by 3 bps to 2.17% in 2025, then plunged by 294 bps to 8.54% in 2026.
- The last three EBITDA Margin figures came in at 8.54% (Q1 2026), 2.17% (Q4 2025), and 9.95% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Rockwell Medical | 29.97 Mn | 5.17 Mn | 3.24 Mn | -5.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.97% |
| Mar 31, 2026 | -8.54% |
| Dec 31, 2025 | -2.17% |
| Sep 30, 2025 | -9.95% |
| Jun 30, 2025 | -8.39% |
| Mar 31, 2025 | -7.19% |
| Dec 31, 2024 | -2.10% |
| Sep 30, 2024 | 6.84% |
| Jun 30, 2024 | 1.99% |
| Mar 31, 2024 | -5.84% |
| Dec 31, 2023 | -2.48% |
| Sep 30, 2023 | -7.31% |
| Jun 30, 2023 | -16.37% |
| Mar 31, 2023 | -7.26% |
| Dec 31, 2022 | -10.18% |
| Sep 30, 2022 | -19.84% |
| Jun 30, 2022 | -23.99% |
| Mar 31, 2022 | -41.09% |
| Dec 31, 2021 | -54.52% |
| Sep 30, 2021 | -43.61% |